(Q61956017)
Statements
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD). (English)
0 references
January 2012
0 references
October 2012
0 references
40
0 references
18 year
0 references